Note 18 - Subsequent Events	9 Months Ended
Sep. 30, 2021
Notes to Financial Statements
Subsequent Events [Text Block]	*18.* Subsequent Events Management evaluated all events or transactions that occurred after September 30, 2021 through the date the financial statements were filed. On November 9, 2021, at the Company’s annual meeting of stockholders, among other routine matters, the Company’s stockholders voted to amend the Plan to increase the number of shares of Common Stock authorized to be issued by 3,000,000 shares, remove the limit on the maximum number of shares covered by an award that may be issued in any calendar year to any single recipient and to make certain modifications to reflect the Company’s name change. On November 9, 2021, and pursuant to a release dated November 8, 2021, the Company remitted cash payment of $2.1 million to a purchaser of Old Cytocom securities to satisfy obligations pursuant to a preferred stock subscription agreement.

The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-URI http://asc.fasb.org/topic&trid=2122774

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 855
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662

Name:	us-gaap_SubsequentEventsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration